Navigation Links
Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year
Date:5/21/2013

CINCINNATI, May 21, 2013 /PRNewswire/ -- Tom Daulton, CEO of Mammotome, a division of Devicor Medical Products, has been named Dealmaker of the Year by the Cincinnati chapter of the Association for Corporate Growth (ACG). Daulton, who was nominated by another local top executive who is also a breast cancer survivor, led the purchase of the Mammotome® brand from Ethicon Endo-Surgery in March of 2010. Daulton will be presented with the award at the formal Deal Maker Awards program, presented by Huntington Bank, on May 22.

The ACG Deal Maker Awards program recognizes the significant achievements of corporations, entrepreneurs, and service providers who have been successful in their pursuit of corporate growth through acquisition, joint venture and/or divestiture transactions.

"Being recognized by an organization as well-respected as ACG is truly an honor," said Daulton.  "Being nominated by a breast cancer survivor made this award even more special to me and is a tribute to the more than 400 Mammotome employees around the world. Knowing that our work has helped someone in their fight against cancer is the greatest recognition of all."

Under Daulton's direction, Mammotome has continued to expand its global presence. In the last three years, the company has continued to develop and release clinically differentiated medical products and technologies that help physicians quickly and accurately diagnose breast cancer. Most recently, Mammotome officially launched its newest product – Mammotome® revolve™.  Mammotome® revolve™ received FDA approval and is available in the United States, Canada and Europe. The unique design of the Mammotome® revolve™ empowers clinical decision-making, increases procedural efficiency, and provides optimized sample retrieval through a patented tissue management technology. Other major new product milestones include the introduction of the tetherless vacuum-assisted biopsy device, Mammotome® elite™, which came to market in the spring of 2012. These products are designed for a faster and simpler procedural experience for both the physician and patient while providing superior tissue samples to help pathologists make a confident diagnosis.

As part of Mammotome's growth strategy, the company has invested heavily in infrastructure, opening offices in Paris, Rome, Seoul, Hamburg, Shanghai, and Tokyo. Recently, the company opened an advanced manufacturing facility in Tijuana, Mexico, and completed a state-of-the-art Global Training Center at the company headquarters in Cincinnati. In 2011, Devicor Medical Products completed the acquisition of the neoprobe® GDS portfolio of products. The company continues to maintain an active pipeline of potential acquisition opportunities.

About Devicor® Medical Products, Inc.
Devicor Medical Products, headquartered in Cincinnati, Ohio, has more than 400 employees around the globe. The company is committed to advancing technology to help clinicians accurately diagnose breast disease, such as breast cancer, through minimally invasive procedures. Devicor's product portfolio includes the world-renowned Mammotome® Breast Biopsy System, neo2000® Gamma Detection System (GDS) and tissue markers (MammoMARK™, MicroMARK®II, and CorMARK™) used in breast disease diagnostic sampling and management. These products are sold in more than 50 countries around the world. Since its introduction in 1995, more than 3.6 million women have had a minimally invasive breast biopsy in stereotactic, ultrasound or MRI-guidance imaging using the Mammotome® Breast Biopsy System. For more information, please visit www.devicormedical.com or www.mammotome.com.


'/>"/>
SOURCE Devicor Medical Products
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Prem Reddy Named Among Most Influential Physician Executives in Nation
2. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
3. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
4. Dr. Phillip Chan Named Finalist for Ernst & Young Entrepreneur of the Year® 2012 Award in New Jersey
5. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
6. StreamVenue Healthcare CEO Named Peoples Choice Winner
7. Masimo CEO Joe Kiani Named Ernst & Young Entrepreneur of the Year
8. Prime Therapeutics Named a Top Workplace by the Minneapolis Star Tribune
9. WellTok Named Colorado Company to Watch for 2012
10. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
11. Nonin Medical Named Platinum Partner by Tri-anim Health Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 28, 2017 , ... Accreditation Commission for Health Care (ACHC) ... America (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s ... Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much more than ... (NSF), going just 19 hours without sleep can compromise motor reaction time, which can increase ... and Amica Insurance is sharing the following tips from the NSF to help you sleep ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery ... the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, ... patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... People are ... older people. “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa ... Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions ... Grove Foundation implement a Microsoft Dynamics GP solution that integrates to their PointClickCare ... that specializes in long-term care, Brooke Grove now has the capability to achieve ...
Breaking Medicine News(10 mins):